In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma

• Helene Hersvik Aarstad,

  Affiliations Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway, Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, Bergen, Norway

  ⨯
• Olav Karsten Vintermyr,

  Affiliations Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Elling Ulvestad,

  Affiliations Department of Microbiology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway

  ⨯
• Kenneth Kross,

  Affiliation Department of Otolaryngology/Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands

  ⨯
• John Helge Heimdal,

  Affiliations Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway, Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, Bergen, Norway

  ⨯
• Hans Jorgen Aarstad

  * E-mail: hans.aarstad@uib.no

  Affiliations Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway, Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, Bergen, Norway

  ⨯